Randomised Standard control clinical trial to evaluate an adjuvant effect of Triphala Darvyadi Ghan Vati in Madhumeha Upadrava with special referance to Diabetic Nephropathy. - NI

Dr. Pratiksha Dundappa Talawar0 个研究点目标入组 0 人开始时间: 待定最近更新: 2023年10月16日

试验速览

暂无简介。

•1.Signs & symptoms of Madhumeha (According to Charakacharya).
•2.Signs & Symptoms of Madhumeha Upadrava related to Diabetic Nephropathy.
•3.Known case of Non-Insulin Dependent Diabetes Mellitus (Type 2 DM).
•4.Patients having HbA1c up to 12.
•6.Patients with fasting blood sugar upto 250 mg/dl & postprandial blood sugar upto 350 mg/dl.
•5.Patients taking oral hypoglycemic agents since 6 months.
•6.Patients having Serum Creatinine level normal to 2.5 mg/dl.

•1.Patients with acute complications like hypoglycemic coma, ketoacidosis and related complications, history of complications, infections like gangrene.
•2.Patients with known chronic diabetic complications such as end stage renal disease, patients receiving dialysis, cardiac complications, neuropathy.
•3.Pregnant and lactating women.
•4.Patients suffering from all major systemic diseases, IHD, TB, HIV, Carcinoma, uncontrolled HTN.

发起方

Dr. Pratiksha Dundappa Talawar